Analyst
Dalit Capital
Equibles does not estimate personal net worth.
Rashmi Shetty is recorded as Analyst at Dalit Capital. Rashmi Shetty has spoken on 4 earnings calls across 4 companies, most recently for Lupin Limited on November 4, 2026. Those appearances were for Lupin Limited, Zydus Lifesciences Limited, Poly Medicure Limited and Mankind Pharma Limited. The companies whose calls Rashmi Shetty spoke on are classified in the Healthcare sector.
“Vinita, what is the addressable market size of Apexab and oral suspension?”
“So just one bookkeeping question on assertio, whatever consideration amount, how are you allocating to, how much are you allocating to goodwill, intangibles or anything in gross block?”
“So again, on the margin front, on the console level, you know, overall gross margin, you said it is in the range of 71 to 72%. But on the console level, our other expenditure and personal cost for this quarter is pretty high.”
“So, one question on this net working capital, you know, you mentioned that, you know, the inventory has been increased, and currently, the working capital is around 52 days.”
Dalit Capital
Analyst
Transcript header (unverified)
Lupin Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Zydus Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Poly Medicure Limited
Medical Instruments & Supplies · Healthcare
Mankind Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Lupin Limited
Earnings Call for the Quarter Ended June 30, 2026
Zydus Lifesciences Limited
Earnings Call for the Quarter Ended June 30, 2026
Poly Medicure Limited
Earnings Call
Mankind Pharma Limited
